Systemic traditional inflammation runs parallel with immune cells trained by atherogenic substance exposure, perpetuating a proinflammatory phenotype: recent research showed that cytokine release is durably enhanced in established atherosclerosis and that cytokines such as CXCL8 and IL-17 are preferential biomarkers of trained immunity [31]. This evidence concerns the gene IL17A and atherosclerosis.